Blue Trust Inc. Grows Holdings in DENTSPLY SIRONA Inc. (NASDAQ:XRAY)

Blue Trust Inc. lifted its position in shares of DENTSPLY SIRONA Inc. (NASDAQ:XRAY) by 10.9% during the 4th quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 7,199 shares of the medical instruments supplier’s stock after acquiring an additional 707 shares during the quarter. Blue Trust Inc.’s holdings in DENTSPLY SIRONA were worth $137,000 as of its most recent SEC filing.

Other institutional investors have also recently modified their holdings of the company. Sound Income Strategies LLC grew its holdings in DENTSPLY SIRONA by 85.0% in the fourth quarter. Sound Income Strategies LLC now owns 242,064 shares of the medical instruments supplier’s stock valued at $4,594,000 after purchasing an additional 111,199 shares during the period. Avior Wealth Management LLC lifted its position in shares of DENTSPLY SIRONA by 21.1% during the 4th quarter. Avior Wealth Management LLC now owns 34,400 shares of the medical instruments supplier’s stock valued at $653,000 after buying an additional 6,000 shares in the last quarter. Nisa Investment Advisors LLC grew its stake in DENTSPLY SIRONA by 89.6% in the 4th quarter. Nisa Investment Advisors LLC now owns 54,397 shares of the medical instruments supplier’s stock valued at $1,041,000 after acquiring an additional 25,705 shares during the period. MassMutual Private Wealth & Trust FSB increased its holdings in DENTSPLY SIRONA by 648.4% in the 4th quarter. MassMutual Private Wealth & Trust FSB now owns 1,422 shares of the medical instruments supplier’s stock worth $27,000 after acquiring an additional 1,232 shares in the last quarter. Finally, UMB Bank n.a. increased its holdings in DENTSPLY SIRONA by 60.8% in the 4th quarter. UMB Bank n.a. now owns 1,492 shares of the medical instruments supplier’s stock worth $28,000 after acquiring an additional 564 shares in the last quarter. 95.70% of the stock is currently owned by institutional investors and hedge funds.

DENTSPLY SIRONA Price Performance

NASDAQ XRAY opened at $19.29 on Thursday. The company has a quick ratio of 0.84, a current ratio of 1.25 and a debt-to-equity ratio of 0.72. DENTSPLY SIRONA Inc. has a 52 week low of $17.21 and a 52 week high of $34.91. The business’s fifty day simple moving average is $19.14 and its 200-day simple moving average is $22.31. The firm has a market cap of $3.83 billion, a PE ratio of -9.32, a P/E/G ratio of 1.88 and a beta of 0.96.

DENTSPLY SIRONA (NASDAQ:XRAY) last posted its earnings results on Thursday, November 7th. The medical instruments supplier reported $0.50 earnings per share for the quarter, beating the consensus estimate of $0.48 by $0.02. The company had revenue of $951.00 million for the quarter, compared to analyst estimates of $939.10 million. DENTSPLY SIRONA had a negative net margin of 10.59% and a positive return on equity of 12.62%. DENTSPLY SIRONA’s revenue was up .4% on a year-over-year basis. During the same period in the previous year, the business posted $0.49 EPS. As a group, equities analysts anticipate that DENTSPLY SIRONA Inc. will post 1.84 earnings per share for the current year.

DENTSPLY SIRONA Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Friday, January 10th. Investors of record on Friday, December 27th were given a $0.16 dividend. The ex-dividend date of this dividend was Friday, December 27th. This represents a $0.64 annualized dividend and a yield of 3.32%. DENTSPLY SIRONA’s payout ratio is -30.92%.

Wall Street Analysts Forecast Growth

XRAY has been the topic of several research analyst reports. UBS Group dropped their target price on shares of DENTSPLY SIRONA from $35.00 to $27.00 and set a “buy” rating on the stock in a research report on Tuesday, December 3rd. Barrington Research lowered their price objective on DENTSPLY SIRONA from $36.00 to $24.00 and set an “outperform” rating on the stock in a report on Friday, November 8th. Jefferies Financial Group cut DENTSPLY SIRONA from a “buy” rating to a “hold” rating and reduced their target price for the company from $30.00 to $20.00 in a report on Thursday, January 23rd. StockNews.com lowered DENTSPLY SIRONA from a “buy” rating to a “hold” rating in a research note on Tuesday, November 19th. Finally, Robert W. Baird dropped their price target on DENTSPLY SIRONA from $31.00 to $24.00 and set a “neutral” rating for the company in a research report on Friday, November 8th. Ten investment analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the company presently has an average rating of “Hold” and a consensus target price of $26.33.

DENTSPLY SIRONA Company Profile

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.